28Serious

Biotech

Ask VT AI

View News Summary

OpenAI and Amazon Web Services strike a $38 billion, seven-year partnership to provide OpenAI with massive computing power for its AI workloads.
Yad Vashem identifies 5 million Holocaust victims, with AI potentially recovering 250,000 more names from millions of documents.
Jon Stewart extends his deal to remain executive producer and host of The Daily Show through 2026, amid Paramount's sale and industry restructuring.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Latest News

Krystal Biotech Reports Q3 2025 Income Surge With Global VYJUVEK Expansion Planned

100% left coverage1 source

Krystal Biotech Reports Q3 2025 Income Surge With Global VYJUVEK Expansion Planned

100% left coverage1 source

Krystal Biotech Reports Q3 2025 Income Surge With Global VYJUVEK Expansion Planned

Krystal Biotech Reports Q3 2025 Income Surge With Global VYJUVEK Expansion Planned

Biotech, Markets

Rigel Pharmaceuticals' Stock Surges Nearly 50% on Strong Biotech Growth

50% center coverage2 sources

Biotech, Markets

Rigel Pharmaceuticals' Stock Surges Nearly 50% on Strong Biotech Growth

50% center coverage2 sources

Rigel Pharmaceuticals' Stock Surges Nearly 50% on Strong Biotech Growth

Rigel Pharmaceuticals' Stock Surges Nearly 50% on Strong Biotech Growth

Purple Biotech Shares Surge Over 90% After Tri-Specific Antibody Manufacturing Breakthrough

100% left coverage1 source

Purple Biotech Shares Surge Over 90% After Tri-Specific Antibody Manufacturing Breakthrough

100% left coverage1 source

Purple Biotech Shares Surge Over 90% After Tri-Specific Antibody Manufacturing Breakthrough

Purple Biotech Shares Surge Over 90% After Tri-Specific Antibody Manufacturing Breakthrough

Biotech, Biotechnology

PDS Biotech Seeks FDA Approval After New NCI Data

100% left coverage1 source

Biotech, Biotechnology

PDS Biotech Seeks FDA Approval After New NCI Data

100% left coverage1 source

PDS Biotech Seeks FDA Approval After New NCI Data

PDS Biotech Seeks FDA Approval After New NCI Data

Trinity Biotech Reports Perceptive Advisors Plans Debt-to-Equity Conversion to Strengthen Balance Sheet

100% left coverage1 source

Trinity Biotech Reports Perceptive Advisors Plans Debt-to-Equity Conversion to Strengthen Balance Sheet

100% left coverage1 source

Trinity Biotech Reports Perceptive Advisors Plans Debt-to-Equity Conversion to Strengthen Balance Sheet

Trinity Biotech Reports Perceptive Advisors Plans Debt-to-Equity Conversion to Strengthen Balance Sheet

Novartis Plans $12B Acquisition to Expand Neuroscience RNA Therapies

50% center coverage2 sources

Novartis Plans $12B Acquisition to Expand Neuroscience RNA Therapies

50% center coverage2 sources

Novartis Plans $12B Acquisition to Expand Neuroscience RNA Therapies

Novartis Plans $12B Acquisition to Expand Neuroscience RNA Therapies

IO Biotech Reports Promising Phase 3 Results for Cylembio and Keytruda in Advanced Melanoma

100% left coverage1 source

IO Biotech Reports Promising Phase 3 Results for Cylembio and Keytruda in Advanced Melanoma

100% left coverage1 source

IO Biotech Reports Promising Phase 3 Results for Cylembio and Keytruda in Advanced Melanoma

IO Biotech Reports Promising Phase 3 Results for Cylembio and Keytruda in Advanced Melanoma

Ask VT AI

View News Summary

OpenAI and Amazon Web Services strike a $38 billion, seven-year partnership to provide OpenAI with massive computing power for its AI workloads.
Yad Vashem identifies 5 million Holocaust victims, with AI potentially recovering 250,000 more names from millions of documents.
Jon Stewart extends his deal to remain executive producer and host of The Daily Show through 2026, amid Paramount's sale and industry restructuring.

20 hours

First 100 Days

See how you scored in predicting Trump's first 100 days

Most Reported By
News from Biotech